Increased CKMB release is a trade-off for optimal stent implantation: an intravascular ultrasound study  by Iakovou, Ioannis et al.
28A ABSTRACTS - ACCIS2002 (Angiography & Interventional Cardiology) JACC March 6, 2002 
ORAL CONTRIBUTIONS 
808 Outcomes With Coronary Stenting 
Monday, March 18, 2002, 9:15 a.m.-l 0:30 a.m. 
Georgia World Congress Center, Room 257W 
9:15 a.m. 
806-1 Emergency Coronary Artery Bypass Grafting Following 
Percutaneous Coronary interventions in the Stent Era 
sSeshadri, Naveen Acharya, Penny Houghtaling, Eugene Blackstone, Stephen 
G. Ellis, Patrick L. Whiilow, Cleveland Clinic Foundation, C/eve/and, Ohio. 
Background: Since the advent of percutaneous coronary interventions. technological 
advances, adjunctive pharmacology and increased operator experience have resulted in 
lower complication rates. We sought to determine the prevalence of and indications for 
emergency coronary artery bypass grafting (EMCABG) following percutaneous intervan- 
tions (PCI) at our institution. 
Methods: A review of all PCls performed between 1992 to 2000. Data was entered pro- 
spectively in a computerized database at the time of PCI and updated at hospital dis- 
charge. 
Results: A total of 16, 561 PCI procedures were performed during the study period. There 
was a need for EMCABG in 113 (0.61%) cases overall. There was a decrease in the 
occurence of EMCABG over time from 1992-2000 (p<O.OOi) (Figure). 
Stents and glycoprotein IlWllla inhibitors were used in 6/<1% (1992-1994), 31/12% (1995), 
59/33% (19X-1997) and 76/7.2% (1996-2000) of all PCls respectively. The predominant 
indications for EMCABG wsre extensive dissection (56% in 1992-96 vs 41% in 1997-00) 
and perforation (19% in 1992-96 vs 24% in 1997-00). 
Summery: 
There has been a significant decrease in the prevalence of EMCABG following PCls over 
the last decade and EMCABG is extremely uncommon in the new millenium. 
9:30 a.m. 
806-2 Outcome of PTCA and Stenting in Diabetic and 
Nondiabetic Patients: A Report From the Total 
Occlusion Study of Canada (TOSCA) investigators 
wDzavik, Kok Meng Yee. Todd Anderson, Eric A. Cohen, John Man&i, Diane 
Catellier, Gerald Barbeau, John Ducas, Charfes Lazzam, Jeffrey R. Burton, Peter B. 
Berger, Christopher E. Buller, Toronto Genera/Hospital, University Health Nefwork, 
Toronto, Ontario, Canada. 
BACKGROUND: Prior studies have suggested worse outcome after percutaneous coro- 
nary intervention in diabetic patients with CAD compared to those without diabetes. How- 
ever, outcome after stenting of non-acute coronary occlusions in those with diabetes is 
unknown. The main aim of this analysis was to compare angiographic and clinical outcome 
in diabetic and non-diabetic patients randomized to PTCA alone or stenting in the TOSCA 
Trial, a multicenter randomized trial of stsnting with a heparincoated Palmaz-Shatz stent 
vs. angioplasty alone in patients with non-acute coronary occlusions (TIMI 0 and 1) 
METHODS: Baseline and follow-up QCA parameters and l-year clinical outcomes for 
PTCA and Stent groups were compared for diabetic and non-diabetic patients. Student t- 
test, Chi-square and Kaplan-Meier analyses were used. 
kuns: 
CONCLUSIONS: Stenting after PTCA of non-acute coronary occlusions results in superior 
net gain and appears to result in similar magnitude of angiographic improvement and 
reduction in NR in diabetic and non-diabetic patients. The increased need for repeat 
revascularization in diabetic patients is a reflection of .sn increase in revascularization of 
non-target vessels. 
Outcome In diabetics and non-diabetics randomized lo stent or PTCA 
Variable Diabetes No Diabetes 
PTCA Stent pvalue PTCA Stent pvalue 
rl=36 n=30 n=170 n=172 
Acute gain in mm 1.6+0.4 2.4*0.6 <O.OOOl 1.9+0.5 2.4i0.6 <O.OOOl 
Net gain in mm. 1.1+0.7 1.5~0.7 0.015 1.2+0.7 1.4~0.7 0.005 
Failure of sustained patency in % 16.4 3.7 0.076 19.6 12.1 0.071 
NR 31.6 20.0 0.261 30.0 21.5 0.023 
Any revascularization 42.1 36.7 0.604 38.8 28.5 0.052 
9:45 a.m. 
806-3 Three-Year Foiiow-Up Results of Argentine Randomized 
Study Coronary Angiopiasty With Stenting Versus 
Bypass Surgery in Patients With Multiple Vessel 
Disease (ERACI ii) 
medo E. R&&uez, Mlximo Rodriguez Alemparte, Julio Baldi. Jose Navia, Jorge 
Martinez, Daniel Vogel, Alajandro Delacasa, Victor Bern&i, Carlos Ferndndez Pereirs., 
lgor Palacios. William O’Neill, Ofamsndi Hospital, Buenos Aires. Argentina, William 
Beaumont Hospital, Royal Oak, Michigan. 
Background: We previously presented the hospital and one year follow up results of the 
Argentine randomized trial percutaneous transluminal coronary revascularization (PTCR) 
with stenting versus coronaty artery bypass graft surgery (CABG) in multivessel disease 
(ERACI Il).Oblsctlve:The purpose of the present study was to report the 3 years follow 
up outcome of the ERACI II study. Methods: This trial included 460 patients (pts) with 
multivessel disease and clinical indication of myocardial revascularization (92% of unsta- 
ble angina) randomized to stent (225) or CABG (225). The primary end point of the study 
was to compare freedom from major adverse events (MACE) as death, myocardial inf- 
arction (Ml), stroke and repeat PTCRICABG, between both rsvascularization procedures 
at 30 days, 1.3 and 5 years of follow up. Results: At 3 years of follow up there were no 
differences in freedom from MACE or from Ml between both groups. Survival at the end 
of the follow up was still significantly better with stent technique compared to CABG (95% 
versus 90.2% respectively, p< 0.044) however this advantage was lower than we 
reported previously (p= 0.017 in favor to PTCR at one year). Freedom from repeat revas- 
cularization procedures were significantly better with surgery (94.7% versus 75%, p< 
0.00001 respectively) and these differences increased during the entire follow up period 
(pz 0.001 in favor to CABG at one year).Concluslon:ln this selected group of pts with 
multivessel disease, at 3 years of follow up, PTCR with stent implantation showed better 
survival than conventional bypass surgery. Repeat revascularization procedures were 
significantly higher in the PTCR group. 
IO:00 a.m. 
806-4 impact of Angiographic Restenosts Detected by 
Routine Anglographic Follow-Up at Six Months on 
Long-Term Mortality 
HelmutSchuhlen, Adnan Kastrati. J&g Hausleitsr, Josef Dirschinger, Veroniks 
Eimannsberger, Julinda Mehilli. Albert Schbmig, Deutsches Herzzenlrum. Munich, 
Germany, 1. Med. Klinik mchts der Isar. Munich, Germany. 
Background. Angiographic routine follow-up at six months (FU angio) is the most sensi- 
tive tool to detect restenosis after coronary stent placement. The impact of angiographic 
restenosis identified by FU angio on long-term prognosis of patients has been ques- 
tioned. 
Methods. We analyzed all patients with FU angio after successful coronary stem place- 
ment from May 1992 throughout December 1996. At our institutions, all patients are rou- 
tinely scheduled for FU angio at six months, and 1972 of 2409 patients consented to this 
procedure. 
Results. Of 1972 patients with FU angio, 562 patients (26.5%) had angiographic rest- 
enosis (>50% diameter stenosis). During the 4-year follow-up, 6.6% of patients with rest- 
enosis died, compared to 6.0% of those without restenosis (p=.OZ). Patients with 
restenosis had several significant differences in clinical and angiographic characteristics: 
they were older, had more diabetes, had more complex and longer lesions in smaller 
vessels which required more stents. However, in a multivariate model including all these 
variables together with restenosis, only older age (adjusted risk, 2.78; 95% confidence 
interval, 2.05-3.77) and restenosis (1.46; 1 .Ol-2.10) were identified as significant and 
independent risk factors for long-term mortality. Of all 562 patients with restenosis, 331 
had a target vessel revascularization procedure (NR) due to symptoms, stenosis ssver- 
ihy or evidence of ischemia. Patients with NR had a long-term mortality of 6.2%. com- 
pared to 9.7% in patients withoutTVA (p=.51). 
Conclurfons. Angiographic restenosis is independently and significantly associated with 
an increased long-term mortality, independent of other well-known risk factors for the 
development of restenosis. 
IO:15 a.m. 
806-5 Increased CKMB Release Is a Trade-Off for Optimal 
Stent implantation: An intravascular Ultrasound Study 
v, R. Merhan. G. Mint& G. Dangas, Y. Koboyashi. A. Abizaid, D. Ashby, T. 
Limpijankit, R. Narasimaiah. I. Hjazi. N. Kipshidze, A. L. Lansky, G. W. Stone, J. W. 
Moses, M. B. Leon, Cardiovascular Research Foundation. Lenox Hill Heart & Vascular 
Institute, New York, New York. 
Introduction. Creatine kinase MB (CKMB) elevation after percutaneous coronary lnter- 
ventions (PCI) is associated with late mortality. We evaluated the impact of aggressive 
stent expansion on both CK-MB release and clinical outcome. 
Methods. We identified 969 consecutive patients (lM19 coronary lesions) who underwent 
intravascular ultrasound (IVUS)-guided stenting; restenotic and saphenous vein graft 
lesions were excluded. Patients were classified based on final stent cross-sectional area 
(CSA): Group I (stent CSAc 70% ref. lumen CSA, 11~117 pts, n=126 lesions), Group II 
@tent CSA: 70-100% ref. lumen CSA, n=551 pts, n=562 lesions), and Group III @tent 
CSA> 100% ref. lumen CSA, n=321 pts, n=327 lesions). CK-MB values were measured 
by radioimmunoassay at baseline, 6 and 24 hours after PCI. 
Results. Baseline patient characteristics and lesion morphology including arc of calcium 
(~~0.7) and diabetes (~~0.67) were similar among the groups. There was a stepwise 
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decrease in TLR (25.6%, 20.7%, 14.5%. p=O.Ol) and death/Q-wave MI (9.5%, 4.4%, 
4.2%, p=O.O5) in groups I, II, and Ill respectively with more aggressive stent expansion at 
one-year follow-up. However, this was associated with a stepwise increase in CK-MB 
release (CK-ME>3 x nomlal : 15.6% vs. 16% vs. 24.7%, p=O.O23). 
these, 99 lesions were found occluded longer than 6 months and constituted the study 
population. Hydrophilic guide wires, Shinobi’ and PT Graph@, were used as the pri- 
mary guide wire to cross the lesion. The angiograms were reviewed and measured by 
quantity analysis. 
Results: There were 61 male and 17 female with age 59i13 years. There were 57 with 
hyperiension(HTN), 34 with diabetes, 49 with hypertipidemia(HLP), 43 with smoking his- 
tory, 9 with heart failure and 12 with prior bypass surgety(CABG). There were 19 lesions 
in left anterior, 24 in left circumflex, 45 in right coronary artery and 1 in ramus. Overall 
successful recanalization was achieved in 62% (61/99). In-hospital outcome included 
only 1 emergent CABG due to perforation.Success rate based on angiographic morphol- 
ogy was analyzed. Patterns of abrupt occlusion were classified as occlusion with no 
stump, with shorl stump and with long stump, and successful rates were 67% (12/36). 
66% (26/32) and 94% (29/31) respectively (p=O.O03). The successful rate was not differ- 
ent between the presence or absence of bridging collaterals, 79% (2Z26) versus 63% 
(59/71) (p=O.4); and not different between the presence or absence of side branch, 62% 
(37145) versus 62% (44/54) (p=O.6). Multivariate analysis revealed the absence of stump 
(p=O.OOl, odds ratio 5.37), absence of HTN(p=0.02, odds ratio 2.53) and absence of 
HLP (p= 0.02, odds ratio 2.71) were the significant variables for failure to cross the CTO. 
Conclusion: With current hydrophilic guide wire, absence of stump was the most signifi- 
cant predictor for failure to cross the CTO. Regardless of bridging collaterals and side 
branch, the success rate of PCI for CT0 is 90% if there is a stump present. 
stent expansioo percent 
Conclusions. Aggresswe stsnt expansion leads to decreased TLR at one year. However, 
this is achieved at the expense of periprocedural CKMB release and non-Q wave Ml. 
ORAL CONTRIBUTIONS 
811 Chronic Total Occlusions 
Monday, March 18, 2002, 11:OO a.m.-12:15 p.m. 
Georgia World Congress Center, Room 264W 
II:00 a.m. 
811-l One-Year Clinical Outcome After Successful 
Percutaneous Coronary Interventions on Chronic Total 
Occlusions: Results From a Multicenter Prospective 
Study 
wOlivari, Federico Piscione. Paolo Rubarlelli, Massimo Dorbano, Leonardo 
Paloscia, Cinzia Marozzini, Silvio Tolaro, Giuseppe De Luca, Paolo Giudice, Ospedale 
Ca ‘For7ce//o, Treviso, Italy 
BACKGROUND: clinical outcome after PCI of chronic total occlusions (CTO) is contro- 
versial. 
OBJECTIVE: one year clinical follow up after successful (SP) or failed PCI (FP) in pts 
with single (SV) or multivessel disease (MV) 
METHODS: TOAST (Total Occlusion Angioplasty STudy) is a multicenter, prospective , 
observational study, enrolling all pts with at least one CT0 (TIMI flow O/l, duration >30 
days) on native vessels.Pts will be followed for 5 years. 
RESULTS: during a study period, 456 CT0 were attempted in 432 pts; 67,3 had angina 
symptoms and 65,3% had a previous MI: SP (TIMI 3 flow and ~50% stenosis) was 
obtained in 334 pts (stems in 66%); 2.5% of pts had in-hospital MACE. One year clinical 
follow up is complete for 95,7% of pts and is shown in the table, with regard 10 the pres- 
ence of SV (columns 2-4) or MV (columns 5-7). The pts with SP and FP had similar base- 
line clinical characteristics. 
SP (167) FP (36) p-value SP (149) FP (49) p-value 
Cardiac death 2 (1.2%) 1 (2.6) 0,46 2 (1,3%) 2 (4,1%) 0,26 
MI (Q/non Cl) 2 (1.2%) - 086 1 (0,7%) 4 (6,20/o) 0,Ol 
Death IQ MI 3 (1,6%) 1 (2,6%) 0.56 3 (2%) 5 (10,2%) 0,02 
TLR (PCI) 16 (9,6%) 4’ (10.5%) 0,7 16 (12,1%) 3’(6,1%) 0.29 
CABG 3 (1,6%) 6 (15,6%) 0,002 7 (4,7%) 11 (22,4%) 0,001 
Event free 143 (656%) 27 (71,1%) 0106 120 (60,5%) 29 (59,2%) 0,002 
TLR= target lesion revascularization;* in 4i7 pts was performed a transmyocardial laser 
revascularization and in 3 a new attempt with PCI. 
Among 319 event free pts, those after SP were more frequently asymptomatic (66,7% vs 
73,7%, p=O,O39); among 274 undergoing stress test, those after SP more frequently per- 
formed a maximal exercise (70,7% vs 49%,p=O.O04). 
CONCLUSIONS: 1) One year after SP a clinical outcome was significantly bensr in terms 
of angina symptoms and exercise tolerance and the pts had a significantly lower need for 
a CABG. 2) Furthermore, pts with MV and SP had a significant reduction of combined 
cardiac deaths and Q MI 
11:15a.m. 
811-2 Chronic Coronary Total Occlusion: A Revisit With 
Current Hydrophilic Guide Wire 
mHo, Ming W. Liu, University of Alabama at Birmingham, Birmingham, 
Alabama. 
Background: Coronary chronic total occlusion (CTO) remains as a clinical challenge in 
percutaneous coronary intervention (PCI) due to a lower success rate, 50-75% depend 
on the case selection. Presence of abrupt occlusion, bridging collaterals and side branch 
at the point of occlusion had been consistently found to be the major predictors for failure 
to cross the CTO. We reexamine these 3 variables with current hydrophilic guide wires. 
Methods: From March 1999 to April 2001, there were 330 total occluded lesions. Among 
11:30 a.m. 
811-3 Treatment of Uncrossable Chronic Total Coronary 
Occlusions With the Frontrunner: Multicenter 
Experience 
mk L. Whitlo& Matthew Selmon, William O’Neill, William Knopf, Eduardo Uruchuriu, 
Antonio Colombo, Eberhard Grube. Hugo Londero, J. Eduardo Sousa, John Simpson, 
The Cleveland Clinic Foundation, Cleveland, Ohio. 
Background: C?ronic Total Occlusion (CTO) remains the most common reason for 
referring a patient with significant coronary artery disease to bypass surgery rather than 
percutaneous coronary intervention (PCI). PCI success in CT& 2 1 year is < 50% 
because of failure to cross with a guidewire in the majority of these cases. Methods: We 
tested the Frontrunner catheter (FRC), a new device designed to radially stretch and 
bluntly dissect the CT0 to enable distal placement of a conventional guidewire to facili- 
tate PTCAIstenting. Results: 100 consecutive patients who failed conventional recanali- 
zation were anempted with the FRC. Patients were eligible only if the target lesion 
proved uncrossable with a guidewire for 2 10 minutes fluoroscopy time. Patient age was 
62 f 10 years; 65% of patients were men. Lesion length was 21 k 6mm (range 2 - 
53mm). Target vessels were 49 RCA, 29 LAD, 17 left circumflex, 1 left main, and 4 
unspecified. The lesion could be engaged with ths device in 79% of cases, and in 56n9 
(71%) the guidewire was positioned in the true lumen beyond the occlusion allowing 
stent deployment. Three different versions of the device were utilized, with successful 
stenting rates improving from 45% initially to 64% with version 2 to 67 % with version 3. 
Complications included 2 perforations requiring pericardiocentesis and 4 small contained 
perforations not requiring treatment. One ostial right coronary dissection caused a small 
aortic hematoma without clinical sequelae. No QMI occurred and no emergency bypass 
surgery was necessary. Conclusions: The Frontrunner appears promising in opening 
chronic total occlusions not crossable with conventional techniques. Evolution of the 
device and operator experience have improved results, and further refinements in cathe- 
ter size and flexibility are in progress. 
Ii:45 a.m. 
811-4 Predicting Success in Crossing Chronic Total 
Occlusions With a New Guidewire 
P. A. Morales, &&a&i R. Hsuse~, E. A. Weirick, C. W. Hatler, St. Luke’s Medical Center/ 
Phoenix Head Center, Phoenix, Arizona. 
Background: Chronic total occlusions (CTOs) are difficult to cross. Conventional wires 
are associated with failure in old occlusions, and standard laser wires are known to fail in 
long occlusions. A new, forward-looking fiberoptic guidance technology (Safe-Steer, 
lntraluminal Therapeutics, Carlsbad. CA) that uses optical coherence reflectometry 
(OCR) to distinguish between intraluminal plaque and the arterial wall has recently dem- 
onstrated successful use in crossing coronary artery CTOs. 
Methods: A total of 30 patients (7 women, 23 men: mean age 63.6 years) with known 
CTOs and confirmed ischemia each underwent an initial lo-minute anempt to cross the 
occlusion with a conventional 0.014” guidewire before it was exchanged for the Safe- 
Steer Wire. A regression analysis was used to analyze the data and evaluate the inde- 
pendent effects of occlusion age and occlusion length on successful intervention with the 
Safe-Steer wire. 
RSSultS: The average lesion length was 45.4 +I- 33.1 mm, and the average age of the 
occlusion was 53.9 +I- 76.9 months. The primaty success rate for crossing CTOs with 
the Safe-Steer guidewire was 66.7% (26/30). Patients were treated with angioplasty 
alOne (10120) or angioplasty and stenting (16/20). There was no evidence of vessel per- 
foration in any patient. Results of the regression analysis indicated neither occlusion age 
nor occlusion length had significant effect (R2~0.041; FcO.36, p=O.762) on the ability to 
cross CTOs with the Safe-Steer wire. 
Conclusions: Initial results indicate OCR technology enables the operator to assess 
intraluminal position and cross most CTOs wthout trauma or perforation, Advanced 
occlusion age and long occlusion length were not related to failure to cross the CTO, 
suggesting the Safe-Steer wire may have a wider therapeutic index than conventional 
wires or other laser wires. 
